DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fa230f/ims_pharmaceutical) has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Finland" report to their offering.
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Key Topics Covered:
HEALTHCARE SYSTEM
- Facts & Figures
- Market Indicators
- Provision & Funding
PRICING
- Prescription Drugs
- Generic Drugs
- Hospital Drugs
- OTC Drugs
REIMBURSEMENT
- Admission to Reimbursement
- Reimbursement Categories
- Reimbursement Prices
- Hospital Reimbursement
- Changes in Reimbursement Status
- Changes in Reimbursement Prices
PHARMACOECONOMICS
- Pharmacoeconomic Requirements
- Price Build Up
- Wholesalers Retail Pharmacies
- Dispensing Doctors
- Sales Tax
COST CONTAINMENT
- Industry Paybacks
- Promotional Costs
- Patient Co-payments
- Prescribing Controls
- Generics
- Rx-to-OTC Switches
- Parallel Trade
FUTURE DEVELOPMENTS
- Outlook
NAMES & ADDRESSES
For more information visit http://www.researchandmarkets.com/research/fa230f/ims_pharmaceutical.
Source: IMS Health